Cargando…
“Malignant” Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi‐Ethnic Study of Atherosclerosis)
BACKGROUND: As heart failure (HF)‐associated morbidity and mortality continue to escalate, enhanced focus on prevention is increasingly important. “Malignant” left ventricular (LV) hypertrophy (LVH): LVH combined with an elevated cardiac biomarker reflecting either injury (high‐sensitivity cardiac t...
Autores principales: | Peters, Matthew N., Seliger, Stephen L., Christenson, Robert H., Hong‐Zohlman, Susie N., Daniels, Lori B., Lima, Joao A.C., de Lemos, James A., Neeland, Ian J., deFilippi, Christopher R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850178/ https://www.ncbi.nlm.nih.gov/pubmed/29437599 http://dx.doi.org/10.1161/JAHA.117.006619 |
Ejemplares similares
-
Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA (Multi‐Ethnic Study of Atherosclerosis)
Publicado: (2019) -
Prevalence of Unexplained Left Ventricular Hypertrophy by Cardiac Magnetic Resonance Imaging in MESA
por: Massera, Daniele, et al.
Publicado: (2019) -
Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA
por: Sparapani, Rodney, et al.
Publicado: (2019) -
Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients
por: Chen, Huanwen, et al.
Publicado: (2019) -
Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients
por: Koycheva, Reneta Yovcheva, et al.
Publicado: (2016)